Search filters

List of works by Ruoji Zhou

A homozygous p53 R282W mutant human embryonic stem cell line generated using TALEN-mediated precise gene editing.

scientific article published on 26 January 2018

Establishment of a human embryonic stem cell line with homozygous TP53 R248W mutant by TALEN mediated gene editing.

scientific article published on 27 April 2018

Generation of a heterozygous p53 R249S mutant human embryonic stem cell line by TALEN-mediated genome editing

scientific article published on 30 November 2018

Generation of an induced pluripotent stem cell line from an individual with a heterozygous RECQL4 mutation

scientific article published on 02 October 2018

Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase.

scientific article published on 2 February 2018

Genomic Integrity Safeguards Self-Renewal in Embryonic Stem Cells

scientific article published on 01 August 2019

Genomic Landscape of Colorectal Mucosa and Adenomas

scientific article published on 24 May 2016

Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.

scientific article published on 14 August 2017

Modeling Cancer with Pluripotent Stem Cells

scientific article

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

scientific article published on 13 June 2018

Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism

article published in the Proceedings of the National Academy of Sciences of the United States of America

Patient-derived iPSCs link elevated mitochondrial respiratory complex I function to osteosarcoma in Rothmund-Thomson syndrome

scientific article published on 29 December 2021

Prognostic Value of a Positive-to-negative Change in Hormone Receptor Status after Neoadjuvant Chemotherapy in Patients with Hormone Receptor–positive Breast Cancer ⬇️

scientific article published on March 22, 2012

The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.

scientific article

[Solid variant of mammary adenoid cystic carcinoma with basaloid features: a clinicopathologic and immunohistochemical study].

scientific article

Paulina is supported by:

About Paulina

Help